---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-029110"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2021-12-22T23:59:59+00:00"
generated_at: "2026-06-27T23:07:32.630190+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne appoints Will Geist President, Protein Sciences Segment, succeeding retiring Dave Eansor

## Summary
- Geist, former COO of Quanterix and former VP/GM at Thermo Fisher, appointed effective Jan 3, 2022.
- He succeeds N. David Eansor, who will retire and assist transition through Feb 2022.
- Base salary $500,000; target cash bonus 85%; annual equity grants ~$1.8M; one-time RSU grant $1M.
- Geist has over 20 years senior life science tools experience; CEO highlighted his experience running >$1B revenue businesses.

## SEC filing metadata
- accession: 0001437749-21-029110
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2021-12-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000143774921029110/0001437749-21-029110-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000143774921029110/tech20211222_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-029110
- JSON: https://secwatch.observer/filing/0001437749-21-029110.json
- Plain text: https://secwatch.observer/filing/0001437749-21-029110.txt

## Key facts
- Executive change
  N. David Eansor departed as President, Protein Sciences Segment at BIO-TECHNE Corp.
  - Action: announced intention to retire
  - Role: President, Protein Sciences Segment
  source text: Mr. Geist succeeds N. David Eansor, who has announced his intention to retire.
  evidence_url: https://www.sec.gov/Archives/edgar/data/842023/000143774921029110/0001437749-21-029110-index.htm
- Executive change
  William Alexander Geist was appointed as President, Protein Sciences Segment at BIO-TECHNE Corp.
  - Action: appointed
  - Role: President, Protein Sciences Segment
  source text: On December 17, 2021, the Compensation Committee of the Board of Directors of Bio-Techne Corporation (the “Company”) appointed Mr. William Alexander Geist, age 52, as an executive officer of the Company in the position of President, Protein Sciences Segment, effective January 3, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/842023/000143774921029110/0001437749-21-029110-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.